Progression after discontinuation of bevacizumab in the first-line treatment of ovarian cancer
@article{ATM108872,
author = {Hidekatsu Nakai and Noriomi Matsumura},
title = {Progression after discontinuation of bevacizumab in the first-line treatment of ovarian cancer},
journal = {Annals of Translational Medicine},
volume = {11},
number = {5},
year = {2023},
keywords = {},
abstract = {},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/108872}
}